← Back to Search

Treatment for Parkinson's Disease (PPMI Trial)

N/A
Recruiting
Led By Caroline Tanner, MD, PhD
Research Sponsored by Michael J. Fox Foundation for Parkinson's Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study intervals ranging from 3 months to 156 months
Awards & highlights

Summary

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study intervals ranging from 3 months to 156 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and study intervals ranging from 3 months to 156 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison between Rates of Change
Comprehensive and uniformly acquired dataset
Establish standardized protocols for acquisition, transfer and analysis of clinical, digital, imaging, biologic and genetic data that can be used by the PD research community.
+2 more

Find a Location

Who is running the clinical trial?

Michael J. Fox Foundation for Parkinson's ResearchLead Sponsor
113 Previous Clinical Trials
530,679 Total Patients Enrolled
Institute for Neurodegenerative DisordersOTHER
48 Previous Clinical Trials
8,514 Total Patients Enrolled
Caroline Tanner, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
500,086 Total Patients Enrolled
~3000 spots leftby Dec 2033
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top